7LZ4 image
Entry Detail
PDB ID:
7LZ4
Keywords:
Title:
Crystal structure of A211D mutant of Protein Kinase A RIa subunit, a Carney Complex mutation
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2021-03-08
Release Date:
2021-05-26
Method Details:
Experimental Method:
Resolution:
4.16 Å
R-Value Free:
0.26
R-Value Work:
0.22
R-Value Observed:
0.22
Space Group:
H 3
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:cAMP-dependent protein kinase type I-alpha regulatory subunit, N-terminally processed
Mutations:A211D
Chain IDs:A, B, C, D, E, F, G, H
Chain Length:269
Number of Molecules:8
Biological Source:Bos taurus
Ligand Molecules
Primary Citation
Noncanonical protein kinase A activation by oligomerization of regulatory subunits as revealed by inherited Carney complex mutations.
Proc.Natl.Acad.Sci.USA 118 ? ? (2021)
PMID: 34006641 DOI: 10.1073/pnas.2024716118

Abstact

Familial mutations of the protein kinase A (PKA) R1α regulatory subunit lead to a generalized predisposition for a wide range of tumors, from pituitary adenomas to pancreatic and liver cancers, commonly referred to as Carney complex (CNC). CNC mutations are known to cause overactivation of PKA, but the molecular mechanisms underlying such kinase overactivity are not fully understood in the context of the canonical cAMP-dependent activation of PKA. Here, we show that oligomerization-induced sequestration of R1α from the catalytic subunit of PKA (C) is a viable mechanism of PKA activation that can explain the CNC phenotype. Our investigations focus on comparative analyses at the level of structure, unfolding, aggregation, and kinase inhibition profiles of wild-type (wt) PKA R1α, the A211D and G287W CNC mutants, as well as the cognate acrodysostosis type 1 (ACRDYS1) mutations A211T and G287E. The latter exhibit a phenotype opposite to CNC with suboptimal PKA activation compared with wt. Overall, our results show that CNC mutations not only perturb the classical cAMP-dependent allosteric activation pathway of PKA, but also amplify significantly more than the cognate ACRDYS1 mutations nonclassical and previously unappreciated activation pathways, such as oligomerization-induced losses of the PKA R1α inhibitory function.

Legend

Protein

Chemical

Disease

Primary Citation of related structures